Washington Trust Advisors, Inc. - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 71 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Washington Trust Advisors, Inc. ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$7,542
-0.6%
2000.0%0.00%0.0%
Q2 2023$7,586
+56.0%
2000.0%0.00%
Q1 2023$4,864
-16.3%
2000.0%0.00%
-100.0%
Q4 2022$5,808
-3.2%
2000.0%0.00%0.0%
Q3 2022$6,000
-14.3%
2000.0%0.00%0.0%
Q2 2022$7,000
-22.2%
2000.0%0.00%0.0%
Q1 2022$9,000
-10.0%
2000.0%0.00%0.0%
Q4 2021$10,0002000.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 565,951$24,483,0008.44%
Murchinson Ltd. 162,703$7,039,0001.34%
Eversept Partners, LP 220,286$9,529,5720.73%
BRANDES INVESTMENT PARTNERS, LP 379,322$16,410,0000.35%
Analyst IMS Investment Management Services Ltd. 17,657$764,0000.07%
Claret Asset Management Corp 7,279$315,0000.06%
ACADIAN ASSET MANAGEMENT LLC 326,427$14,086,0000.06%
Renaissance Technologies 678,300$29,343,0000.03%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 191,820$8,298,0000.03%
ARK Investment Management 55,566$2,404,0000.01%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders